Enter your login e-mail to the account
Search
Search parameters
Search results
- Cardiorenal syndromes from nephrologist`s perspective
Doc. MUDr. Katarína Gazdíková, PhD., MHA, MPH, mim. prof.
(5/2018, Review articles ) - Chronic kidney disease – role of nephrologist and general practitioner
Prof. MUDr. Romana Ryšavá, CSc.
(2/2015, Interdisciplinary consilium ) - MANAGEMENT OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
doc. MUDr. Ladislav Chovan, CSc.
(2/2006, Main topic ) - Ovlivnění progrese chronických nefropatií inhibitory angiotenzin konvertujícího enzymu a antagonisty angiotenzinu
prof. MUDr.ladimír Tesař, DrSc.
(2/2004, clearly ) - TREATMENT OF ARTERIAL HYPERTENSION IN ELDERLY PEOPLE AND IN DEMENTIA PREVENTION
prof. MUDr. Zoltán Mikeš, DrSc.
(7-8/2006, Main topic ) - ANKYLOSING SPONDYLITIS – NEWS IN THERAPY
prof. MUDr. Jozef Rovenský, DrSc., FRCP, MUDr. Daniel Žlnay, CSc., MUDr. Martin Žlnay
(1/2008, Topic ) - Therapy of osteoarthritis
MUDr. Oľga Lukáčová, PhD., doc. MUDr. Jozef Lukáč, PhD.
(3/2015, Review articles ) - PHARMACOTHERAPEUTIC APPROACHES FOR RHEUMATOID ARTHRITIS
prof. MUDr. Jozef Rovenský, DrSc., MUDr. Ivan Rybár, MUDr. Dagmar Mičeková, CSc., MUDr. Daniel Žlnay, PhD., doc. MUDr. Jozef Lukáč, CSc., MUDr. Peter Poprac, PhD.
(2/2005, Topic ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - The diagnosis and treatment of multiple sclerosis
doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(4/2015, Interdisciplinary consilium ) - Tehotenstvo u pacientok so sclerosis multiplex
MUDr. Marianna Vitková, PhD.
(3/2018, Interdisciplinary consilium ) - Glaucoma
MUDr. Erika Vodrážková, MUDr. Branislav Trnavec
(5/2011, Interdisciplinary consilium ) - Prevention or sloving the progression of diabetic nephropathy. Fact or fiction?
MUDr. Vladimír Uličiansky
(4/2016, Review articles )
- Ocrelizumab – clinical evaluation and disease progression – 6,5 years data
MUDr. Eva Recmanová
(5/2021, Review articles ) - Familial amyloid polyneuropathy
doc. MUDr. Peter Špalek, PhD.
(6/2013, Main topic ) - Farmakoterapia Parkinsonovej choroby – poznámky k situácii v SR
doc. MUDr. Ján Benetin, CSc.
(S2/2009, Supplement ) - Glycogen storage disease type II (GSD II, Pompe disease). Current diagnostic and therapeutic options. Clinical case report
MUDr. Věra Malinová
(5/2010, Review articles ) - NEDA-4 concept as a treatment outcome in multiple sclerosis patients
MUDr. Pavel Hradílek, Ph.D.
(3/2016, Review articles ) - Diabetic Neuropathy – Neurologist Perspective
MUDr. Tomáš Nedělka, doc. MUDr. Martin Bojar, CSc., MUDr. Radim Mazanec, Ph.D.
(6/2009, Review articles ) - Treatment of secondary progressive multiple sclerosis with siponimod and a case report
MUDr. Veronika Tichá, Ph.D.
(6/2021, Review articles ) - Magnetic resonance and sclerosis multiplex
MUDr. Víťazoslav Belan, PhD., MUDr. Monika Daňová
(2/2014, Main topic ) - B-cell targeted therapy to impact the progression of multiple sclerosis
MUDr. Martin Elišák, Ph.D.
(3/2023, Review articles ) - The late-onset form of Pompe disease
MUDr. Radka Mišurová, MUDr. Věra Malinová
(4/2021, Case reports ) - The influence on long-term progression of multiple sclerosis – brighter days ahead?
MUDr. Dominika Šťastná, doc. MUDr. Dana Horáková, Ph.D.
(1/2021, Review articles ) - Correlation between magnetic resonance imaging and clinical disability in multiple sclerosis
prof. MUDr. Zdeněk Seidl, CSc., doc. MUDr. Manuela Vaněčková, Ph.D.
(5/2014, Review articles ) - Ocrelizumab and novel therapeutic goals in multiple sclerosis
MUDr. Radek Ampapa
(2/2020, Review articles )
- Lysosomal storage diseases: current diagnostic and therapeutic options
MUDr. Věra Malinová, doc. MUDr. Tomáš Honzík, Ph.D.
(3/2013, Review articles )
- Effectiveness and safety of abiraterone acetate treatment for metastatic castration-resistant prostate cancer post-chemotherapy
MUDr. Tomáš Hradec, FEBU, MUDr. Otakar Čapoun, FEBU
(2/2018, Review articles ) - Immunotherapy in the bladder cancer treatment: long-term results
MUDr. Petr Hušek, FEBU, MUDr. Jaroslav Pacovský, Ph.D., MUDr. Miroslav Podhola, Ph.D., prof. MUDr. Miloš Broďák, Ph.D.
(4/2020, Communication from practice )
- Klinická skúsenosť s liečbou mnohopočetného myelómu monoklonálnou protilátkou v monoterapii – kazuistika
MUDr. Natália Štecová
(4/2018, Original articles ) - Overview of treatment of castration-resistant prostate cancer
MUDr. Jana Obertová
(4/2012, Review articles ) - Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - Myelodysplastic syndrome – medicine made to measure
MUDr. Eva Mikušková, doc. MUDr. Ján Staško, PhD., MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(6/2014, Spectrum ) - Systemic treatment of high-grade gliomas relapse or progression
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA
(5/2016, Main topic ) - Gastrointestinal stromal tumors
MUDr. Jozef Šufliarsky, PhD.
(1/2011, Review articles ) - Treatment of multiple myeloma
MUDr. Emília Flochová, PhD., MUDr. Lucia Stančiaková
(5/2016, Spectrum ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - Publikujeme v zahraničí
(5/2016, Information & comments ) - Osteonecrosis – complication at oncological treatment in childhood
doc. MUDr. Emília Kaiserová, CSc., MUDr. Anna Foltinová CSc., MUDr. Víťazoslav Belan, PhD., MUDr. Ľubica Pružincová, doc. MUDr. Emil Huraj, CSc., MUDr. Zlatica Pavlovičová
(1/2009, Review articles ) - THE TREATMENT EFFECT EVALUATION OF MALIGNANT LYMPHOMAS
MUDr. Jan Hudeček, CSc., MUDr. Ivana Plameňová, MUDr. Juraj Chudej
(2/2008, Review articles ) - TARGETED THERAPY OF HEAD AND NECK CANCERS – A CASE STORY
MUDr. Dagmar Sorkovská, MUDr. Dušan Poruban, CSc., prof. MUDr. Štefan Galbavý, DrSc.
(2/2008, Original articles ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Publikujeme v zahraničí
(3/2014, Information & comments ) - 18F-choline PET/CT in evaluation of therapeutic response of castration-resistant prostate cancer
Doc. MUDr. Soňa Balogová, PhD., MUDr. Lucia Noskovičová, MUDr. Lucia Kaliská FEBMN , MUDr. Marika Vereb, FEBMN, MUDr. Marek Bartovic
(3/2015, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Gastrointestinal malignancies – current position of imunotherapy
MUDr. Dominik Šafčák, PhD., doc. MUDr. Igor Andrašina, CSc.
(1/2023, Main topic ) - Bevacizumab in the treatment of patients with ovarian carcinoma
MUDr. Michaela Kubíčková, MUDr. Jozef Šufliarsky, PhD., MUDr. Štefánia Lišková, MUDr. Tomáš Minárik, PhD., MUDr. Andrej Jurík, MUDr. Tibor Lengyel, PhD., MUDr. Igor Slezák, PhD.
(6/2015, Original articles & case reports ) - Pixantrone in the treatment of relapsed/refractory aggressive B-non Hodgkin›s lymphomas: a retrospective data analysis
MUDr. Radoslav Greksák, PhD., MUDr. Miriam Ladická, doc. MUDr. Ľuboš Drgoňa, CSc., MHA, FECMM
(1/2023, Original articles ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Topotecan in the treatment of recurrent ovarian carcinoma – the retrospective analysis
doc. MUDr. Jozef Mardiak, CSc., MUDr. Jozef Šufliarsky, MUDr. Oliver Sadovský, CSc., MUDr. Tomáš Minarik, MUDr. Michaela Kubíčková, MUDr. Tibor Lengyel, MUDr. Bohuslav Nižňanský
(6/2009, Original articles & case reports ) - Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Place of bosutinib in the therapy of chronic myeloid leukemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Angelika Bátorová, PhD.
(3/2016, Drugs & drug classes ) - Neurobiology of cancer: from empirism to evidences
doc. MUDr. Boris Mravec, PhD.
(5/2011, Review articles ) - Treatment and prognosis of patients with hairy cell leukaemia treated in 1996 – 2010 at the National Cancer Institute in Bratislava
MUDr. Miriam Ladická, MUDr. Ľudmila Demitrovičová, MUDr. Radoslav Greksák, PhD., MUDr. Iveta Oravcová, PhD.
(4/2011, Original articles & case reports ) - Publikujeme v zahraničí
(3/2016, Information & comments ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, Review articles ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Therapy and metaphylaxis of non muscle invasive bladder cancer (TaT1, CIS)
doc. MUDr. Milan Obšitník, CSc.
(5/2010, Review articles ) - Ewing sarcoma – our treatment experiences
MUDr. Vanda Mikudová, MUDr. Andrej Jurík, MUDr. Michaela Kubíčková, MUDr. Tomáš Minárik, PhD., MUDr. Silvia Cingelová, PhD., MUDr. Jozef Šufliarsky, PhD., MUDr. Michaela Sojáková, PhD.
(1/2019, Main topic ) - HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMOPOIETIC CELL TRANSPLANTATION
MUDr. Ján Gyárfáš
(5/2008, Review articles ) - Kritériá minimálnej reziduálnej choroby pri chronickej lymfocytovej leukémii
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Zriedkavý nádor hrudníka: malígny pleurálny mezotelióm
MUDr. Lucia Denková, MUDr. František Sándor, PhD., FCCP
(3/2018, Main topic ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - Publikujeme v zahraničí
(1/2015, Information & comments ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Biological therapy in colorectal cancer
MUDr. Jozef Dolinský
(2/2011, Review articles ) - THE INTRODUCTION TO INTERPRETATION OF CLINICAL TRIALS – Part II.
MUDr. Michal Mego, PhD., MUDr. Mária Rečková
(3/2008, Review articles ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Treatment of inicially metastatic small-cell lung cancer
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, doc. MUDr. Mária Tamášová, CSc.
(5/2013, Review articles ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - GASTROINTESTINAL STROMAL TUMOR – A COMPREHENSIVE VIEW OF DIAGNOSTICS AND TREATMENT
MUDr. Andrea Cipková, MPH.
(6/2008, Review articles ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Integrating bevacizumab in the first line treatment of ovarian cancer – the retrospective analysis
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová, RNDr. Jana Koperdáková, PhD.
(5/2015, Original articles & case reports ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - Treatment of gastrointestinal stromal tumours
MUDr. Zdeněk Linke, MUDr. Jana Prausová
(4/2010, Review articles ) - Publikujeme v zahraničí
(1/2017, Information & comments ) - Management of PSA progression after topical treatment of prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(S1/2020, Case reports ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - Smoldering multiple myeloma
prof. MUDr. Elena Tóthová, CSc.
(2/2016, Spectrum ) - Continuuing treatment of hepatocellular carcinoma with sorafenib after radiological progression – case report
MUDr. Eva Pritzová, MUDr. Matej Hrnčár
(2/2016, Original articles & case reports ) - Experience with exemestane in daily practise
MUDr. Jana Obertová, MUDr. Ivana Zigová
(3/2009, Original articles & case reports ) - Recommendations for the treatment of patients with polycythaemia vera in the Slovak Republic
MUDr. Antónia Hatalová, PhD., MUDr. Alexander Wild, MUDr. Anna Vallová, MUDr. Tomáš Guman, PhD., MUDr. Monika Hlebašková, MUDr. Juraj Chudej, PhD., MUDr. Emília Flochová, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Ľubica Lukáčová
(S1/2022, Supplement ) - Liečba pacienta s anaplastickým oligodendrogliómom – kazuistika
MUDr. Martin Chorváth, PhD., MPH, MUDr. Zuzana Piňáková, MUDr. Boris Rychlý, PhD., MUDr. Pavol Povinec, PhD., MUDr. Víťazoslav Belan, PhD., MUDr. Elena Bolješíková, CSc.
(4/2018, Original articles )
- Giant basal cell carcinomas of skin – contribution to problematics of large lesions development and a presentation of three cases
MUDr. Vladimír Bartoš, MUDr. Dušan Pokorný, MUDr. Oľga Zacharová, prof. MUDr. Katarína Adamicová, PhD., MUDr. Milada Kullová, doc. MUDr. Martin Péč, PhD., MUDr. Ivan Mačuga
(1/2012, Original articles & case reports ) - Ki-67 antigen and p53 protein expression in basal cell carcinoma of the skin – a topic review
MUDr. Milada Kullová, MUDr. Vladimír Bartoš, PhD.
(2-3/2013, Review articles ) - A contribution about a proliferative activity as a histomorphological prognostic parameter in malignant melanoma of the skin
MUDr. Milada Kullová, MUDr. Vladimír Bartoš, PhD.
(4/2012, Review articles )
- GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, clearly ) - ACE – INHIBITORS AND AT1R – ANTAGONISTS ARE THE FIRST LINE MEDICATION FOR IgA NEPHROPATHY
prof. MUDr. Karel Matoušovic, DrSc.
(2/2008, Drug classes )
- Profile pharmacotherapy of osteoarthritis in terms of a pharmacist
Doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PhD., PharmDr. Ľubica Lehocká, PhD., PharmDr. Kristína Mihová
(1/2017, Current pharmacotherapy ) - The biological therapy of patients with rheumatoid arthritis
MUDr. Oľga Lukáčová, PhD., Doc. MUDr. Jozef Lukáč, PhD.
(1/2017, Current pharmacotherapy )
- Chronic cerebrospinal venous insufficiency and its controversial relationship with multiple sclerosis
MUDr. Juraj Maďarič, PhD., MPH, MUDr. Ivan Vulev, PhD., MPH, FCIRSE
(1/2014, Main topic ) - Arterial hypertension – a risk factor for cardiovascular complications
doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Matej Bendžala, MUDr. Andrea Komorníková, MUDr. Dáša Mesárošová, PhD., MUDr. Dávid Baláž, doc. MUDr. Peter Gavorník, PhD., prof. MUDr. Andrej Dukát, CSc.
(1/2013, Main topic )